Douglas Elliman Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on January 14, 2022, reporting events occurring on January 10, 2022. The filing discloses the execution of new employment agreements for two senior executives: Howard M. Lorber, appointed President and Chief Executive Officer, and Richard J. Lampen, appointed Executive Vice President and Chief Operating Officer. Both agreements became effective as of December 29, 2021.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation terms.
- Howard M. Lorber (CEO): Annual base salary of $1,800,000 with a target bonus opportunity of 150% of base salary. Includes a $3,750 monthly lodging allowance, car and driver, and corporate aircraft usage.
- Richard J. Lampen (COO): Annual base salary of $650,000 with a target bonus opportunity of 112.5% of base salary. Includes first-class travel, lodging, and corporate aircraft usage.
Material Changes
The primary material change is the formalization of executive leadership compensation structures effective late 2021. No financial performance changes or operational shifts are reported in this document.
Outlook, Risks, and Contingencies
The filing details significant contingent liabilities related to executive severance and change-in-control provisions:
- Termination without Cause/Good Reason:
- Lorber: Entitled to 36 months of continued base salary, annual cash bonus (capped at target), and welfare benefits. Includes accelerated vesting of equity.
- Lampen: Entitled to 24 months of continued base salary, annual cash bonus (capped at target), and welfare benefits. Includes accelerated vesting of equity.
- Change in Control:
- Lorber: If terminated within two years of a change in control, receives a lump sum equal to 2.99 times the sum of base salary and prior year bonus. Includes 36 months of life and medical insurance and full equity acceleration.
- Lampen: If terminated within two years of a change in control, receives a lump sum equal to 2 times the sum of base salary and prior year bonus. Includes 24 months of life and medical insurance and full equity acceleration.
Both executives are bound by non-compete and non-solicitation covenants.
Investor Verification Checklist
- Verify the total potential cash payout for CEO and COO severance under a "Change in Control" scenario.
- Review the attached Exhibits 10.1 and 10.2 for the complete legal definitions of "Cause," "Good Reason," and "Change in Control."
- Assess the impact of the $1.8M and $650K base salaries on the company's operating expense guidance for the upcoming fiscal year.
- Confirm the status of any outstanding equity awards subject to accelerated vesting upon termination.